Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

OXFORD, United Kingdom and HOUSTON , June 5, 2026 /PRNewswire/ -- Optellum , a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more than 3 million cases to date. This milestone underscores Optellum's commitment to empowering health systems and clinical care teams with the tools needed to identify, prioritize, and manage high-risk lung nodules more effectively. This commercial momentum is supported by first-of-their-kind partners